Macro creatine kinase type 2: results of a prospective study in hospitalized patients.
We determined total CK activity with the N-acetylcysteine-activated method and residual activity after immunoinhibition of the CK-M subunits in the sera of 2018 patients consecutively admitted to our university hospital for internal diseases, and of 936 outpatients, regardless of the patients' diagnoses. We could detect not more than two types of macro CK: macro CK type 2, which we observed in the sera of 85 patients (prevalence, 3.7% for hospitalized patients), and macro CK type 1. Most patients showing macro CK type 2 were older than 50 years, but we additionally observed a second peak at 20-30 years of age. We saw no preponderance by sex. We detected macro CK type 2 predominantly in severely ill patients of all ages, mainly those with malignant tumors or cirrhosis of the liver. Our findings support the assumption that macro CK type 2 is the manifestation of mitochondrial CK in serum. Occasionally, macro CK type 2 disappeared from the circulation after amelioration of the associated disease. Its occurrence in serum nevertheless is a sign of a serious illness with high mortality but not inevitably a sign of impending death.
D000328:Adult; D000368:Aged; D000375:Aging; D002318:Cardiovascular Diseases / Q000201:enzymology; D003402:Creatine Kinase / Q000097:blood*; D005260:Female; D006760:Hospitalization; D006801:Humans; D007527:Isoenzymes; D008107:Liver Diseases / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000201:enzymology; D011446:Prospective Studies; D012737:Sex Factors
D007527:Isoenzymes; D003402:Creatine Kinase